Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Operating Income of -$192.02 million for fiscal year 2025.
RHYTHM PHARMACEUTICALS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$192.02M | +27.7% |
| 2024 | -$265.50M | -44.0% |
| 2023 | -$184.36M | -2.9% |
| 2022 | -$179.16M | -5.3% |
| 2021 | -$170.06M | -24.5% |
| 2020 | -$136.57M | +6.5% |
| 2019 | -$146.00M | -86.2% |
| 2018 | -$78.42M | -141.9% |
| 2017 | -$32.41M | -25.1% |
| 2016 | -$25.91M | -145.0% |
| 2015 | -$10.57M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$52.65M | -20.0% | -16.2% |
| June 30, 2025 | -$45.30M | -11.9% | +3.6% |
| March 31, 2025 | -$47.00M | +66.4% | -7.1% |
| September 30, 2024 | -$43.88M | +0.2% | -8.4% |
| June 30, 2024 | -$40.48M | +13.1% | +71.1% |
| March 31, 2024 | -$139.89M | -166.3% | -218.3% |
| September 30, 2023 | -$43.95M | -11.9% | +5.7% |
| June 30, 2023 | -$46.60M | -3.3% | +11.3% |
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +27.7% in Operating Income compared to the prior fiscal year.
- Over the 2015–2025 period, RHYTHM PHARMACEUTICALS, INC.’s operating income has declined by 1716.1% (from -$10.57 million to -$192.02 million).
- The most recent figure is from RHYTHM PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: